InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,499.32
(
1.00%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DarkKnight83

Send PM Follow Ignore
Followers 83
Posts 4211
Boards Moderated 0
Alias Born 03/29/2012

DarkKnight83

Re: KingErik999 post# 80101

Saturday, 06/22/2013 8:53:11 AM

Saturday, June 22, 2013 8:53:11 AM

Post# of 158400
90% of all start up companies biotech or not reports -O- income. Why would they have a revenue stream with no product? Once they have a marketable FDA approved product then they can attract big pharma to buy them out! I never heard of any start-up penny stock company making millions of dollars in revenue with no product! There will be a drastic change in PPS this July as FDA response is expected to come any day now that will initiate clinical trials on humans.

Click on the link below to see why biotech companies need to dilute and what operating expenses they have?

http://www.dataev.com/it-experts-blog/bid/290624/4-Reasons-Biotech-Startups-Can-t-Afford-to-Skimp-on-IT
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up